ORGO

Conviction 20HealthcareScan · Mon, Aug 10, 2026

Inverted hammer

ORGO$1.86+0.00%

ResistanceSupportVol 14

Vol MA14 1.17M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Organogenesis Holdings Inc.PHARMACEUTICAL PREPARATIONSwww.organogenesis.com ↗

Price1.86

Change+0.00%

Gap+0.00%

Rel volume3.36×

Avg volume1.04M

Avg $ vol2.31M

SMA 202.42

SMA 502.42

SMA 2003.40

Price vs 50-23.00%

Price vs 200-45.22%

MA stackbearish

50/200 cross—

Supertrenddown · 2.31

RSI (14)27

MACD hist-0.07

MACD crossbear · 7d

Stoch %K / %D28 / 28

ADX (14)19

+DI / −DI16 / 45

RSI divergence—

MACD divergence—

ATR %+9.70%

ADR %6.19%

52w high6.54

52w low1.86

From 52w high-71.56%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width35.29%

%B-0.15

Donchian pos27.83%

Donchian high2.69

Donchian low1.54

AVWAP (52w high)3.35

vs AVWAP high-44.51%

AVWAP (52w low)1.82

vs AVWAP low+2.34%

OBV trendDown

Chaikin MF (20)0.17

Today vs 20d3.36×

Avg vol (14d)1.17M

Avg vol (20d)1.04M

Avg $ vol (20d)2.31M

Market cap239.33M

RS 3m (vs SPY)-32.18%

RS 6m (vs SPY)-63.98%

RS line new highNo

Trend template0/8

Technical rank4.9

1 week-20.51%

1 month-22.50%

3 months-21.52%

6 months-50.66%

1 year-58.85%

YTD-59.87%

P/E6.46

P/B1.61

P/S0.42

P/FCF-9.78

EPS0.1500

Div yield—

ROE24.98%

ROA9.11%

Debt/Eq0.33

Current3.52

EV/EBITDA4.05

Gross margin64.93%

Net margin6.56%

Rev growth17.04%

EPS growth4201.05%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value242.87M

Revenue43.76M

Net income-96.27M

Gross profit62.97M

Free cash flow-24.46M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out128.67M

Employees854

ListedTue, Nov 29, 2016

Free float71.94M

Float %55.9%

Short interest13.13M

Days to cover16.9d

Short volume58.6%

Squeeze score89 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank4.9 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ORGO

All disclosures →

No recent disclosed trades by Congress in ORGO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ORGO · 1 buy · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Grow Brian Chief Commercial Officer · Class A Common Stock · 2025-01-10	Exercise	958	$1K	2025-01-10	2026-04-24
Grow Brian Chief Commercial Officer · Stock Option (Right to Buy) · 2025-01-10	Exercise	958	$0	2025-01-10	2026-04-24

SEC filings

EDGAR filings in ORGO · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.